Updated Jul 16, 2026
Hirsch Andrew has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-18 | CCCC | C4 Therapeutics, Inc. | F — Tax withholding / forfeiture | 9.1K | $1.89 | $17K |
| 2026-02-18 | CCCC | C4 Therapeutics, Inc. | M — Option exercise | 20.4K | $0.00 | |
| 2026-02-18 | CCCC | C4 Therapeutics, Inc. | F — Tax withholding / forfeiture | 39.2K | $1.89 | $74K |
| 2026-02-18 | CCCC | C4 Therapeutics, Inc. | M — Option exercise | 81.7K | $0.00 | |
| 2026-02-18 | CCCC | C4 Therapeutics, Inc. | A — Grant or award | 700.0K | $0.00 | |
| 2024-11-12 | CCCC | C4 Therapeutics, Inc. | F — Tax withholding / forfeiture | 5.5K | $6.04 | $34K |
| 2024-11-12 | CCCC | C4 Therapeutics, Inc. | M — Option exercise | 12.5K | — |
Hirsch Andrew is a corporate insider — currently tracked as Director of Editas Medicine, Inc. (EDIT). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Hirsch Andrew profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.